PODCAST · health
NephSpace
by Wael Hussein
NephSpace makes new kidney research easy and fun to follow.Every week, Dr. Wael Hussein, an academic nephrologist in Memphis, picks the most interesting new papers and news in nephrology, and two hosts talk them through: the story, the key numbers, why it matters, and an honest take on what the study does and doesn't prove.Weekly episodes cover that week's picks from the kidney journals, the big general journals and the specialty news. Deep Dives follow one question further: two treatments racing for the same goal, a trial worth arguing about, a case that a new paper answers.Made for nephrologists and nephrology fellows.Physician-led, AI-assisted. The hosts are AI voices. Disclosures are in every episode's notes.For education and information only, not medical advice. Please talk to your own physician or care team about your health. Full disclaimer: nephspace.com/disclaimer. Views are the creator's own and not those of his employer. Papers are summarized in our own words, with
Episodes
-
Weekly · Oct 20: Intermittent or Continuous Dialysis in the ICU, Fluid Creep, Deprescribing and the Dialysis Bike
For years, most of us thought it didn't matter whether critically ill patients started on intermittent hemodialysis or continuous therapy. In the ICRAKI trial, starting on intermittent hemodialysis was linked to more deaths, and the trial stopped early. We explain why the size of that gap is...
-
Weekly · Oct 12: Fluids or Pressors, ICU Bicarbonate and What's Holding Back PD
Three reflexes worth rethinking. In septic shock in the emergency department, stopping the fluid and starting the vasopressor early showed no difference in days alive and out of the hospital compared with the classic fluids-first approach, with about half the extra fluid. In a blinded ICU trial,...
-
Deep Dive · Two Desks: Should AI Write the Fellow's Notes?
A 60-page referral, nine years of creatinine, and an AI summary waiting on two desks: the attending's and the first-year fellow's. A Kidney360 perspective says to hand drafting, summarizing and paperwork to AI first, because a clinician checks the draft. A CJASN perspective says that same…
more -
Weekly · Oct 5: Drugs for CKD and Dialysis, the Heart on Dialysis, and a Camera for Fistulas
A new lipid guideline makes reduced kidney function a reason for a statin; in 2024, before it arrived, most patients for whom kidney function is now the reason had no statin prescription. An editorial asks whether GLP-1 drugs belong in dialysis units before the trials are done. A review says...
-
Trailer · Why NephSpace
I want to keep up with nephrology. But the new papers sit behind logins and scattered across sites, so I end up doomscrolling instead. NephSpace brings the week's kidney research and news together, out loud: one weekly episode on what's new, plus deep dives in between, made for the couch, the run...
-
Deep Dive · Two Roads: Hemodiafiltration or Medium Cutoff Dialyzers?
Two dialysis patients, same city, same week. One gets a new machine that filters and replaces more than 20 liters every session. The other gets the same old machine with a new filter. Both are told it's the future. Hemodiafiltration has a survival trial but needs new machines. Medium cutoff...
-
Weekly · Oct 2: The Middle-Molecule Race, a Dipstick Adherence Check, and AI for Fellows
Two ways to clear more middle molecules arrive in US dialysis units at once. A urine dipstick can show whether patients are taking their SGLT2 inhibitor. Two papers disagree about who should let AI write the notes. Nine picks from the week of September 21, 2026, each with the story, the numbers…
more
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
NephSpace makes new kidney research easy and fun to follow.Every week, Dr. Wael Hussein, an academic nephrologist in Memphis, picks the most interesting new papers and news in nephrology, and two hosts talk them through: the story, the key numbers, why it matters, and an honest take on what the study does and doesn't prove.Weekly episodes cover that week's picks from the kidney journals, the big general journals and the specialty news. Deep Dives follow one question further: two treatments racing for the same goal, a trial worth arguing about, a case that a new paper answers.Made for nephrologists and nephrology fellows.Physician-led, AI-assisted. The hosts are AI voices. Disclosures are in every episode's notes.For education and information only, not medical advice. Please talk to your own physician or care team about your health. Full disclaimer: nephspace.com/disclaimer. Views are the creator's own and not those of his employer. Papers are summarized in our own words, with
HOSTED BY
Wael Hussein
Loading similar podcasts...